- He specialises in financial institutions and capital markets law and corporate law.
- He advises on capital market matters, such as the trading in financial instruments, acquisition of major shareholdings, public tender offers, delisting and issuer disclosure obligations. He regularly advises capital companies on internal corporate services.
- He provides regulatory advice to Polish and foreign financial institutions and fintechs, particularly investment firms and payment institutions.
- He also takes part in M&A projects, particularly those involving public companies, with the participation of private equity and venture capital funds, and in the new technologies and video games sector. He supervises the preparation of due diligence reports, and negotiates and drafts main transaction agreements.
- He makes use of his transaction and corporate support experience in his role as leader of the DZP | Future project, advising and supporting entrepreneurs seeking financing on the start-up market.
- Member of the Warsaw Bar Association of Advocates.
-
DZP advises Protective Industrial Products on the acquisition of part of the Honeywell business
Deals corner | 16.12.2024
Katarzyna Biarda, Margarita Kobojek, Maciej Zajda, Tymon Grabarczyk, Katarzyna Zwierz-Wilkocka, Anna Okła-Woźniak have supported the client in signing the purchase agreement.
-
DZP advises international fund investing in Giganci Programowania
Deals corner | 02.12.2024
Our experts have supported a global investment group in providing funding to an education and technology startup offering programming courses for children and young people.
-
DZP advisers engaged in acquisition on mobile games market
Deals corner | 27.11.2024
DZP experts, in cooperation with Latham & Watkins, have advised Miniclip on its buyout of Easybrain, a company previously owned by the Embracer mobile games group.
-
DZP once again advises Michal Lach on an investment in a listed biotech company
Deals corner | 17.07.2024
The co-founder of Audioteka and eTutor – with the support of DZP advisers Maciej Goszczyk, Margarita Kobojek and Maciej Zajda – has become the main shareholder in Pure Biologics.